Sano Genetics is at the forefront of the personalised medicine trend:Its platform accelerates the process for bringing new drugs to market, by bringing the right patients onto the trial and leveraging AI to manage all aspects of clinical trialsIt connects patients across four countries including the US, UK, Canada a.
At-risk families of patients diagnosed with motor neurone disease (MND), better known in the US as amyotrophic lateral sclerosis (ALS) will now have access to genetic sequencing thanks to a financial award from Innovate UK.